Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Entamoeba histolytica | cysteine proteinase, putative | 0.0623 | 0.4933 | 0.3182 |
Trypanosoma cruzi | cysteine proteinase, putative | 0.048 | 0.2568 | 0.2568 |
Trypanosoma cruzi | cysteine peptidase (N-terminal), putative | 0.048 | 0.2568 | 0.2568 |
Brugia malayi | cathepsin L-like precursor | 0.0623 | 0.4933 | 0.4933 |
Brugia malayi | Cathepsin L-like cysteine proteinase | 0.0623 | 0.4933 | 0.4933 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0623 | 0.4933 | 0.3182 |
Schistosoma mansoni | cathepsin F (C01 family) | 0.0623 | 0.4933 | 0.4933 |
Loa Loa (eye worm) | hypothetical protein | 0.0623 | 0.4933 | 0.4933 |
Loa Loa (eye worm) | hypothetical protein | 0.0623 | 0.4933 | 0.4933 |
Schistosoma mansoni | SmCL2-like peptidase (C01 family) | 0.048 | 0.2568 | 0.2568 |
Echinococcus granulosus | cysteine protease | 0.048 | 0.2568 | 0.2568 |
Trypanosoma cruzi | cysteine proteinase, putative | 0.048 | 0.2568 | 0.2568 |
Brugia malayi | Papain family cysteine protease containing protein | 0.048 | 0.2568 | 0.2568 |
Brugia malayi | Cathepsin L-like precursor | 0.0623 | 0.4933 | 0.4933 |
Trichomonas vaginalis | Clan CA, family C1, cathepsin L-like cysteine peptidase | 0.0623 | 0.4933 | 0.3182 |
Echinococcus granulosus | cathepsin L | 0.048 | 0.2568 | 0.2568 |
Echinococcus multilocularis | cathepsin L | 0.048 | 0.2568 | 0.2568 |
Trypanosoma cruzi | cysteine peptidase, clan CA, family C1, cathepsin L-like, putative | 0.0623 | 0.4933 | 0.4933 |
Echinococcus granulosus | cathepsin l1 | 0.0623 | 0.4933 | 0.4933 |
Brugia malayi | Cathepsin L-like precursor | 0.0623 | 0.4933 | 0.4933 |
Brugia malayi | Papain family cysteine protease containing protein | 0.048 | 0.2568 | 0.2568 |
Schistosoma mansoni | SmCL2-like peptidase (C01 family) | 0.048 | 0.2568 | 0.2568 |
Echinococcus granulosus | cathepsin L cysteine protease | 0.048 | 0.2568 | 0.2568 |
Loa Loa (eye worm) | hypothetical protein | 0.0623 | 0.4933 | 0.4933 |
Trypanosoma cruzi | cysteine protease, putative | 0.048 | 0.2568 | 0.2568 |
Trypanosoma cruzi | cysteine peptidase, putative | 0.048 | 0.2568 | 0.2568 |
Schistosoma mansoni | SmCL2-like peptidase (C01 family) | 0.048 | 0.2568 | 0.2568 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GI50 (functional) | -4.863 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SN12C Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.556 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HOP-92 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.55 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SF-539 Central Nervous System cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.536 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the HL-60(TB) Leukemia cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.341 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the SK-MEL-5 Melanoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.284 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the NCI-H23 Non-Small Cell Lung cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4.13 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the UO-31 Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
GI50 (functional) | -4 | PUBCHEM_BIOASSAY: NCI human tumor cell line growth inhibition assay. Data for the ACHN Renal cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.